BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30304348)

  • 1. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
    Kim CC; Berry EG; Marchetti MA; Swetter SM; Lim G; Grossman D; Curiel-Lewandrowski C; Chu EY; Ming ME; Zhu K; Brahmbhatt M; Balakrishnan V; Davis MJ; Wolner Z; Fleming N; Ferris LK; Nguyen J; Trofymenko O; Liu Y; Chen SC;
    JAMA Dermatol; 2018 Dec; 154(12):1401-1408. PubMed ID: 30304348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
    Fleming NH; Egbert BM; Kim J; Swetter SM
    JAMA Dermatol; 2016 Dec; 152(12):1327-1334. PubMed ID: 27542070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
    Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
    JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.
    Kim CC; Swetter SM; Curiel-Lewandrowski C; Grichnik JM; Grossman D; Halpern AC; Kirkwood JM; Leachman SA; Marghoob AA; Ming ME; Nelson KC; Veledar E; Venna SS; Chen SC
    JAMA Dermatol; 2015 Feb; 151(2):212-8. PubMed ID: 25409291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of moderately dysplastic nevi with positive histologic margins.
    Hiscox B; Hardin MR; Orengo IF; Rosen T; Mir M; Diwan AH
    J Am Acad Dermatol; 2017 Mar; 76(3):527-530. PubMed ID: 28027827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative predictive value of biopsy margins of dysplastic nevi: A single-institution retrospective review.
    Duncan JR; Purnell JC; Stratton MS; Pavlidakey PG; Huang C; Phillips CB
    J Am Acad Dermatol; 2020 Jan; 82(1):87-93. PubMed ID: 31326466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.
    Lozeau DF; Farber MJ; Lee JB
    J Am Acad Dermatol; 2016 Jan; 74(1):68-74. PubMed ID: 26549250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
    Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
    JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of conservative 2- to 3-mm surgical margins for complete excision of biopsy-proven severely dysplastic nevi: Retrospective case series at a tertiary academic institution.
    Soleymani T; Swetter SM; Hollmig ST; Aasi SZ
    J Am Acad Dermatol; 2020 Jul; 83(1):254-255. PubMed ID: 31972255
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.
    Tripp JM; Kopf AW; Marghoob AA; Bart RS
    J Am Acad Dermatol; 2002 May; 46(5):674-82. PubMed ID: 12004306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of biopsies and excisions of dysplastic acral nevi: a study of 187 lesions.
    Bronsnick T; Kazi N; Kirkorian AY; Rao BK
    Dermatol Surg; 2014 Apr; 40(4):455-9. PubMed ID: 24456372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border.
    Hocker TL; Alikhan A; Comfere NI; Peters MS
    J Am Acad Dermatol; 2013 Apr; 68(4):545-551. PubMed ID: 23127472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dysplastic nevus: recognition and management.
    Barnhill RL; Hurwitz S; Duray PH; Arons MS
    Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of dysplastic nevus syndrome and early melanoma.
    Devereux DF
    Oncology (Williston Park); 1990 Jan; 4(1):73-81; discussion 82-3. PubMed ID: 2144182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dysplastic melanocytic nevus].
    Salava A; Ranki A; Saksela O
    Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.
    Strazzula L; Vedak P; Hoang MP; Sober A; Tsao H; Kroshinsky D
    J Am Acad Dermatol; 2014 Dec; 71(6):1071-6. PubMed ID: 25262175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysplastic (or Atypical) Nevi Showing Moderate or Severe Atypia With Clear Margins on the Shave Removal Specimens Are Most Likely Completely Excised.
    Maghari A
    J Cutan Med Surg; 2017; 21(1):42-47. PubMed ID: 27436823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of observation in the management of atypical nevi.
    Kmetz EC; Sanders H; Fisher G; Lang PG; Maize JC
    South Med J; 2009 Jan; 102(1):45-8. PubMed ID: 19077745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.